Monopar Therapeutics Inc. (MNPR)
USD 29.94
(-2.41%)
USD 29.94
(-2.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.85 Million | -7.22 Million | -7.31 Million | -4.66 Million | -3.01 Million | -2.88 Million |
| Net Income | -8.4 Million | -10.51 Million | -9.1 Million | -6.3 Million | -4.22 Million | -3.22 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.89 Million | 1.64 Million | 1.46 Million | 1.32 Million | 1.01 Million | 529.33 Thousand |
| Change in working capital | -1.35 Million | 1.64 Million | 317.76 Thousand | 443.8 Thousand | 196.02 Thousand | -188.15 Thousand |
| Other non-cash items | 3.23 Million | 162.96 Thousand | 1.06 Million | -122.4 Thousand | 767.63 Thousand | 441.64 Thousand |
| Investing Cash Flow | 4.92 Million | -4.91 Million | - | - | - | - |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.88 Million | -4.91 Million | - | - | - | - |
| Sales/Maturities of investments | 12.8 Million | - | - | - | - | - |
| Other Investing Activities | 4927.75 | -4918.51 | - | - | - | - |
| Financing Cash Flow | 2.02 Million | 32.87 Thousand | 10.87 Million | 8.18 Million | 9.34 Million | -206.27 Thousand |
| Debt repayment | - | - | - | -122.4 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -46.97 | -76.63 | -63.25 | - | - | - |
| Common Stock Issuance | 2.07 Million | 109.33 Thousand | 10.92 Million | 8.17 Million | 10.22 Million | -206.27 Thousand |
| Other Financing Activities | -46.96 Thousand | -76.38 Thousand | -45.71 Thousand | 129.22 Thousand | -874.81 Thousand | -206.27 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.33 Million | 1.47 Million | 403.96 Thousand | 447.59 Thousand | 243.53 Thousand | 87.68 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -20.41 Thousand | 167.51 Thousand | -86.19 Thousand | -3789.00 | -47.51 Thousand | -275.84 Thousand |
| Cash at beginning of period | 8.18 Million | 20.3 Million | 16.73 Million | 13.21 Million | 6.89 Million | 9.78 Million |
| Cash at end of period | 7.26 Million | 8.18 Million | 20.3 Million | 16.73 Million | 13.21 Million | 6.89 Million |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | -16.79 Thousand | -3478.00 | 4624.00 | 3334.00 | -8574.00 | -2396.00 |
| Net cash flow / Change in cash | -920.11 Thousand | -12.11 Million | 3.56 Million | 3.52 Million | 6.32 Million | -2.88 Million |
| Free Cash Flow | -7.85 Million | -7.22 Million | -7.31 Million | -4.66 Million | -3.01 Million | -2.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.71 Million | -1.64 Million | -1.81 Million | -8.4 Million | -1.95 Million | -2.19 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 334.39 Thousand | 328.66 Thousand | 474.2 Thousand | 1.89 Million | 474.13 Thousand | 473.29 Thousand |
| Change in working capital | -295.87 Thousand | -342.85 Thousand | -206.19 Thousand | -1.35 Million | -460.21 Thousand | -374.77 Thousand |
| Other non-cash items | 680.14 Thousand | 639.9 Thousand | 687.2 Thousand | 3.23 Million | 971.02 Thousand | 845.02 Thousand |
| Investing Cash Flow | -2423.00 | -983.3 Thousand | 2.97 Million | 4.92 Million | -13.05 Thousand | 2.95 Million |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2423.00 | -983.3 Thousand | 9236.00 | -7.88 Million | -2.96 Million | -1.96 Million |
| Sales/Maturities of investments | - | - | 2.96 Million | 12.8 Million | 2.95 Million | 4.91 Million |
| Other Investing Activities | -2.42 | -983.31 | 2970.44 | 4927.75 | -13.05 | 2953.81 |
| Financing Cash Flow | -9919.00 | 3.18 Million | 334.54 Thousand | 2.02 Million | 246.7 Thousand | 641.17 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -10.00 | -10.74 | -5.32 | -46.97 | -8.21 | -16.61 |
| Common Stock Issuance | 83.00 | 3.19 Million | 339.87 Thousand | 2.07 Million | 254.91 Thousand | 657.79 Thousand |
| Other Financing Activities | -10 Thousand | -10.73 Thousand | -5322.00 | -46.96 Thousand | -8207.00 | -16.59 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -345.75 Thousand | -311.23 Thousand | -212.99 Thousand | -1.33 Million | -496.88 Thousand | -371.72 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 49.87 Thousand | -31.61 Thousand | 6809.00 | -20.41 Thousand | 36.67 Thousand | -3049.00 |
| Cash at beginning of period | 7.8 Million | 7.26 Million | 5.51 Million | 8.18 Million | 7.21 Million | 5.72 Million |
| Cash at end of period | 6.11 Million | 7.8 Million | 7.26 Million | 7.26 Million | 5.51 Million | 7.21 Million |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | 1492.00 | -1652.00 | -8357.00 | -16.79 Thousand | 6758.00 | -4354.00 |
| Net cash flow / Change in cash | -1.68 Million | 541.49 Thousand | 1.75 Million | -920.11 Thousand | -1.69 Million | 1.48 Million |
| Free Cash Flow | -1.67 Million | -1.65 Million | -1.54 Million | -7.85 Million | -1.93 Million | -2.1 Million |
CCNEP
TMUS
6634
3497
0KU1
6944